<bill session="104" type="hr" number="449" updated="2013-07-14T18:47:00-04:00">
  <state datetime="1996-06-06">REFERRED</state>
  <status>
    <introduced datetime="1996-06-06"/>
  </status>
  <introduced datetime="1996-06-06"/>
  <titles>
    <title as="introduced" type="official">Relating to breast implants, the Food and Drug Administration, and breast care.</title>
  </titles>
  <sponsor id="411178"/>
  <cosponsors>
    <cosponsor id="400057" joined="1996-06-06"/>
    <cosponsor id="400532" joined="1996-06-06"/>
    <cosponsor id="300040" joined="1996-09-05"/>
    <cosponsor id="400155" joined="1996-07-23"/>
    <cosponsor id="400180" joined="1996-06-06"/>
    <cosponsor id="300151" joined="1996-06-06"/>
    <cosponsor id="405939" joined="1996-07-23"/>
    <cosponsor id="400204" joined="1996-07-23"/>
    <cosponsor id="400205" joined="1996-06-06"/>
    <cosponsor id="406082" joined="1996-09-05"/>
    <cosponsor id="400243" joined="1996-06-06"/>
    <cosponsor id="407817" joined="1996-07-23"/>
    <cosponsor id="407838" joined="1996-07-23"/>
    <cosponsor id="408092" joined="1996-06-06"/>
    <cosponsor id="400288" joined="1996-09-05"/>
    <cosponsor id="400318" joined="1996-06-06"/>
    <cosponsor id="409718" joined="1996-07-23"/>
    <cosponsor id="400377" joined="1996-07-23"/>
    <cosponsor id="400421" joined="1996-06-06"/>
    <cosponsor id="400541" joined="1996-09-05"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1996-06-06">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="1996-06-07">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1032-1033"/>
    </action>
    <action datetime="1996-06-14">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Artificial implants"/>
    <term name="Autoimmune diseases"/>
    <term name="Breast cancer"/>
    <term name="Commerce"/>
    <term name="Education"/>
    <term name="Educational policy"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Health education"/>
    <term name="Joint diseases"/>
    <term name="Product safety"/>
    <term name="Women"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary>6/6/1996--Introduced.
Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.</summary>
</bill>
